Novel imidazopyridine compound ii with therapeutic effect

Details for Australian Patent Application No. 2004249655 (hide)

Owner AstraZeneca AB

Inventors Nordberg, Peter

Agent Freehills

Pub. Number AU-B-2004249655

PCT Pub. Number WO2004/113339

Priority 0301904-9 26.06.03 SE

Filing date 23 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 17 April 2008

International Classifications

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61K 31/437 (2006.01)

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/113339 Priority application(s): WO2004/113339

17 April 2008 Application Accepted

  Published as AU-B-2004249655

14 August 2008 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249658-New process for the production of melagatran

2004249640-Guide, assembled guide and device for conditioning products displaceable along a guide track